NTNX.NASDAQNutanix, INC

Form 4: Bain Capital's Max de Groen Reports Nutanix Share Conversion Following Regulatory Approval

Sentiment:

SEC Form 4


Max de Groen, Partner at Bain Capital Investors, reports the conversion of $817.6 million in convertible notes into 16.85 million shares of Nutanix Class A common stock following regulatory approval.

Summary

  • Max de Groen, a director of Nutanix, filed a Form 4 detailing a transaction on July 22, 2024.
  • The transaction involved the conversion of $817,632,828 in 2.50% Convertible Senior Notes due 2026 into 16,854,032 shares of Class A Common Stock.
  • The conversion was executed by BCPE Nucleon (DE) SPV, LP, an entity affiliated with Bain Capital Investors.
  • The conversion was triggered after the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvement Act of 1976, which occurred on July 22, 2024.
  • The conversion price was based on a 25-trading day trailing volume-weighted average price of approximately $65.51 per share.
  • The principal amount of the convertible notes was settled in cash, with the remainder settled in Class A common stock.
  • De Groen disclaims beneficial ownership of the shares except to the extent of his pecuniary interest.
  • The report also mentions 37,100 shares of Class A Common Stock held directly, including 6,088 unvested restricted stock units.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The conversion of notes into equity is a standard financial transaction. While it dilutes existing shareholders, it also reduces debt and signals confidence from a major investor.

Positives

  • The conversion of the notes into equity could be seen as a positive sign, indicating confidence in Nutanix's future prospects by Bain Capital.
  • The settlement of the principal amount in cash reduces Nutanix's debt obligations.

Negatives

  • The conversion results in dilution of existing shareholders' equity.

Risks

  • The market may react negatively to the dilution of shares, potentially impacting the stock price.
  • Future conversions of similar instruments could further dilute shareholder value.

Future Outlook

The document does not provide specific forward-looking statements beyond the maturity date of the convertible notes and the potential for future conversions.

Industry Context

This transaction reflects ongoing investment activity in the technology sector, with private equity firms like Bain Capital playing a significant role in providing capital and influencing corporate strategy.

Comparison to Industry Standards

  • Convertible note conversions are a common financing strategy in the tech industry, often used by companies like Nutanix to raise capital without immediately diluting existing shareholders.
  • The conversion price of approximately $65.51 per share is a key metric, reflecting the market's valuation of Nutanix at the time of the agreement.
  • Similar transactions can be seen with other tech companies that have utilized convertible notes, such as Tesla and MicroStrategy, although the specific terms and conditions vary.

Stakeholder Impact

  • Shareholders will experience dilution of their equity due to the issuance of new shares.
  • The company's debt burden is reduced by the cash settlement of the principal amount of the convertible notes.

Key Dates

DateDescription
August 26, 2020Date of the initial investment agreement regarding the Convertible Notes.
September 24, 2020Date of the amendment to the investment agreement.
July 1, 2024Date the $817,632,828 principal amount of convertible notes was settled in cash.
July 22, 2024Date of the reported transaction and the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvement Act.
July 24, 2024Date of the Form 4 filing.
September 15, 2026Maturity date of the Convertible Notes.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.